16:20 to 16:45
Symposium

AML Therapy in 2024: increasingly individualized approaches

Session 5

Courtney DiNardo
First International THEMA Leukemia Symposium
16:20 to 16:45
    Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot
    Open to all, subject to availability
    -

    Speaker(s)

    Courtney DiNardo

    Events

    Opening speech
    Hugues de Thé, Lise Alter & Matthieu Resche-Rigon

    Symposium
    09:00 to 09:30
    Not recorded

    Therapy Response and Resistance of AML Stem Cells to Venetoclax
    Andreas Trumpp

    Symposium
    09:30 to 09:50

    Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling
    Andrew Lane

    Symposium
    10:00 to 10:20

    Overcoming Therapy Resistance in Acute Myeloid Leukemia
    Alexandre Puissant

    Symposium
    10:30 to 10:50

    Regulation of Hematopoietic Stem Cell Dormancy
    Nina Cabezas

    Symposium
    11:10 to 11:40

    Unmasking Myeloproliferative Neoplasms Transformation Paths
    Lina Benajiba

    Symposium
    11:40 to 12:00

    AML State-Switched
    Clemens Schmitt

    Symposium
    12:05 to 12:30
    Not recorded

    Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML
    Marc Raaijmakers

    Symposium
    14:30 to 14:55

    Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia
    Diana Passaro

    Symposium
    14:55 to 15:20
    Not recorded

    Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun…
    David Michonneau

    Symposium
    15:20 to 15:40

    Quality of Life Matters: A patient perspective
    Emmanuel Raffoux

    Symposium
    16:00 to 16:20

    AML Therapy in 2024: increasingly individualized approaches
    Courtney DiNardo

    Symposium
    16:20 to 16:45

    VEXAS Syndrome in 2024
    Olivier Kosmider

    Symposium
    16:45 to 17:05

    Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl…
    Régis Peffault de Latour

    Symposium
    17:05 to 17:30

    Tracking Human Hematopoietic Stem Cell Clones in Health and Disease
    Lars Velten

    Symposium
    09:00 to 09:25

    Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia
    Emmanuelle Clappier

    Symposium
    09:25 to 09:50

    From Metabolic Vulnerabilities to Targeted Therapies in Leukemia
    Guillaume Andrieu

    Symposium
    09:50 to 10:15

    Developmental Origins of Childhood Leukemia: why does it matter?
    Anindita Roy

    Symposium
    10:15 to 10:40

    AML: Lessons from the Genome
    Timothy Ley

    Symposium
    11:00 to 11:25
    Not recorded

    Targeting Evil Enhancers and Genes in AML
    Ruud Delwel

    Symposium
    11:25 to 11:50

    Targeting Cystine Import in AML
    Raphael Itzykson

    Symposium
    11:50 to 12:20

    Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor…
    Keisuke Ito

    Symposium
    13:50 to 14:15

    Targeting Microenvironmental Drivers of Blood Malignancies
    Bethan Psaila

    Symposium
    14:15 to 14:40
    Not recorded

    Any Crosstalk in the Treatment of AML and HR-MDS
    Lionel Adès

    Symposium
    14:40 to 15:10

    Clonal Evolution of Genetic Predisposition to Hematological Malignancies
    Marie Sebert

    Symposium
    15:30 to 15:50

    PML Unravels New Insights into the Bases of AML Chemotherapy Response
    Domitille Rérolle

    Symposium
    15:50 to 16:15

    Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation
    Paresh Vyas

    Symposium
    16:15 to 16:40

    See also

    Hugues de Thé, chair Cellular and Molecular Oncology
    First International THEMA Leukemia Symposium